• Profile
Close

Two staging systems for gastrointestinal stromal tumors in the stomach: Which is better?

BMC Gastroenterology Dec 10, 2017

Park CH, et al. - The long-term prognosis of patients who underwent surgical resection for gastric gastrointestinal stromal tumors (GISTs) was determined in this study. Moreover, the clinical efficacy of 2 staging systems was compared: the National Institutes of Health (NIH) consensus criteria and the 7th Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) tumor-node-metastasis (TNM) staging system. Among patients who underwent curative resection for gastric GISTs, the 5-year recurrence-free survival (RFS) rate was excellent. Compared to the NIH consensus criteria, the UICC/AJCC TNM staging system could be more useful for risk categorization of patients with gastric GISTs.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay